Physician profile
Ronak Patel
NPI 1629509088
$1,493.11
in general payments reported to CMS, 2019-2025
10 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $159 · 2024: $330 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063 · Travel and Lodging: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.87 |
| Travel and Lodging | $430.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $725.92 | 2025 | Endurant Iis, Valiant Captivia |
| Silk Road Medical, INC. | $297.27 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Bard Peripheral Vascular, INC. | $141.72 | 2023 | Venovo |
| Endologix LLC | $127.34 | 2025 | Torus Stent Graft System, Endocross Device |
| Bolton Medical INC | $90.28 | 2025 | Gelweave, Treo Abdominal Stent-Graft System |
| Lemaitre Vascular, INC. | $32.93 | 2024 | Trivex System, Artegraft Vascular Graft |
| Stryker Corporation | $27.89 | 2025 | Artix Mt |
| Boston Scientific Corporation | $17.38 | 2023 | Solyx Sis System |
| Polynovo North America LLC | $16.74 | 2025 | Novosorb Btm |
| Ethicon US, LLC | $15.64 | 2025 | Stratafix, Evarrest, Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronak Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.